Veterinary and Comparative Oncology

Article	Citations
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	22
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	21
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy	20
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours	19
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy	19
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours	17
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	16
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	16
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	15
Issue Information	15
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping	13
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain	13
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	12
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	12
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs	11
Blood biomarkers for canine cancer, from human to veterinary oncology	11
	11
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study	11
Issue Information	10
	10
Corrigendum	10
Author Index	9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells	9

Issue Information	9
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus	9
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas	9
Issue Information	8
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs	8
	8
Cover Image	8
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma	8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	8
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	8
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs	8
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours	8
	8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)	7
Issue Information	7
Author Index	7
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs	7
Issue Information	7
Issue Information	7
	7
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)	6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma	6
Issue Information	6
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma	6
	6
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma	6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue	6
Comparison of the anticancer effects of various statins on canine oral melanoma cells	5
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	5
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study	5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance	5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire	5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	5
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study	5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience	5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	5
	5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases	5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study	5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs	4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	4
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy	4
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells	4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission	4
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	4
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”	4

Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	4
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	4
	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma	4
	4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases	4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma	4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	4
VCS abstract	4
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study	3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay	3
Issue Information	3
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	3
	3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour	3
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours	3
The animal's microbiome and cancer: A translational perspective	3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade	3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease	3
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate	3
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	3
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	3
Issue Information	3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas	2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases	2
	2
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐118	2
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors	2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study	2
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	2
Issue Information	2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy	2
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy	2
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma	2
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies	2
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas	2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours	2
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma	2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours	2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration	2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma	2
Cover Image	2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma	2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology	2
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma	2
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?	2
VCS 2024 Abstracts	2
Axillary lymphadenectomy in dogs: A description of surgical technique	2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	2
	2
Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and TRBC2 in Canine Lymphoid Tumour Cell Lines and Normal Lymphocytes	2
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours	2
Author Index	2
Issue Information	2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	2
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	2
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	2
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	2
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)	1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity	1

Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment	1
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate	1
Response of canine thyroid carcinomas to radioiodine	1
	1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy	1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	1
Staging canine patients with appendicular osteosarcoma utilizing fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography	1
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer	1
Editorial	1
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours	1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
Issue Information	1
An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	1
Issue Information	1
	1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications	1
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution	1
	1
Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease	1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis	1
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	1
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer	1
Issue Information	1
Issue Information	1
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas	1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	1
A retrospective comparison of first and second opinion histopathology with patient outcomes in veterinary oncology cases (2011–2019)	1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study	1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	1
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study	1
Abstracts	1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	1
Editorial	1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma	1
	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)	1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma	1
Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance	1